Safety-Driven Ocrelizumab Discontinuation Vs Continuation: Comparative Insights From MSBase
Loading...
Date
2025
Journal Title
Journal ISSN
Volume Title
Publisher
Sage Publications Ltd
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
Description
Keywords
Fields of Science
Citation
WoS Q
Q1
Scopus Q
Q1
Source
Multiple Sclerosis Journal
Volume
31
Issue
3
Start Page
369
End Page
370
